Sanofi deal to supply H1N1 vacc to Brazil
Sanofi Aventis says it has been contracted to supply the Brazilian government with up to 33 million doses of H1N1 “swine” flu.
Sanofi Aventis says it has been contracted to supply the Brazilian government with up to 33 million doses of H1N1 “swine” flu.
The FDA has issued an import alert against products manufactured at two Apotex facilities after the agency issued a warning letter, which raised several issues that the company is now working to resolve.
Bangladesh represents a “huge opportunity” to pharma, according to the CEO of Amreteck Pharma who believes that CMOs will be attracted by the low costs, which undercut China, and help the industry grow to $10bn (€6.9m) in 10 years.
Dutch authorities have completed validation of Solvay Biologicals cell-based production facility which the company will use to meet growing worldwide demand for influenza vaccines.
US discovery chemistry contractor ChemBridge has made some of its most popular small molecule libraries available on-line through a partnership with preclinical data specialist Collaborative Drug Discovery (CDD).
New multi-million dollar R&D contracts with top three pharma and biotech players go someway to “alleviating” the negative impact of downturn, according to Lab Research CEO Luc Mainville.
Transcrip Partners’ “augmentation” solution for contract R&D “differs from the normal consultancy alternative by fielding ‘doers’ who can think strategically and ‘thinkers’ who are happy to get their hands dirty” according to senior partner Paul Branthwaite.